Diagnostics and Tools September 2022

Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.

• MBio Diagnostics, Inc. was acquired by Heska Corporation (NasdaqCM:HSKA)
• Biosynex SA (ENXTPA:ALBIO) announced its acquisition of Theradiag SA
• RayzeBio, Inc. closed a $160mm Series A Financing, led by Sofinnova Investment, Inc., Laurion Capital Management LP, Sectoral Asset Management Inc., Boyu Capital Consultancy Co. Ltd., British Patient Capital Limited, and StartX